Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence by Kube, Dianne M et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
Respiratory Research
Open Access Research
Relation of exaggerated cytokine responses of CF airway epithelial 
cells to PAO1 adherence
Dianne M Kube, David Fletcher and Pamela B Davis*
Address: Department of Pediatrics, Case Western Reserve University School of Medicine, BRB 8th floor, 2109 Adelbert Rd. Cleveland, OH 44106, 
USA
Email: Dianne M Kube - dmkube@adelphia.net; David Fletcher - david.fletcher@case.edu; Pamela B Davis* - pamela.davis@case.edu
* Corresponding author    
Cystic FibrosisInflammationPseudomonas aeruginosaIL-8NeuraminidaseTight junctions
Abstract
In many model systems, cystic fibrosis (CF) phenotype airway epithelial cells in culture respond to
P. aeruginosa with greater interleukin (IL)-8 and IL-6 secretion than matched controls. In order to
test whether this excess inflammatory response results from the reported increased adherence of
P. aeruginosa to the CF cells, we compared the inflammatory response of matched pairs of CF and
non CF airway epithelial cell lines to the binding of GFP-PAO1, a strain of pseudomonas labeled
with green fluorescent protein. There was no clear relation between GFP-PAO1 binding and
cytokine production in response to PAO1. Treatment with exogenous aGM1 resulted in greater
GFP-PAO1 binding to the normal phenotype compared to CF phenotype cells, but cytokine
production remained greater from the CF cell lines. When cells were treated with neuraminidase,
PAO1 adherence was equalized between CF and nonCF phenotype cell lines, but IL-8 production
in response to inflammatory stimuli was still greater in CF phenotype cells. The polarized cell lines
16HBEo-Sense (normal phenotype) and Antisense (CF phenotype) cells were used to test the
effect of disrupting tight junctions, which allows access of PAO1 to basolateral binding sites in both
cell lines. IL-8 production increased from CF, but not normal, cells. These data indicate that
increased bacterial binding to CF phenotype cells cannot by itself account for excess cytokine
production in CF airway epithelial cells, encourage investigation of alternative hypotheses, and
signal caution for therapeutic strategies proposed for CF that include disruption of tight junctions
in the face of pseudomonas infection.
Background
Chronic infection of the lung with Pseudomonas aeruginosa
and the inflammatory response it stimulates cause much
of the morbidity and nearly all the mortality in CF
patients. Since the inflammatory response can be reduced
pharmacologically in CF patients without allowing infec-
tion to increase and with benefit to the patient [1], and
since infants and young children with CF have inter-
leukin-8 (IL-8) and neutrophil count in BAL fluid signifi-
cantly in excess of that observed for non-CF children with
comparable bacterial burden [2,3], many investigators
have concluded that the inflammatory response is exces-
sive and deleterious in the CF lung [reviewed in [4]].
Though the cellular origin of the excessive inflammatory
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response in CF is not fully established, in vivo mouse
CFTR complementation data suggest that the airway epi-
thelium plays a substantive role in driving excess inflam-
mation [5]. In many, but not all, model systems, CF
airway epithelial cells respond to P. aeruginosa or its prod-
ucts with increased IL-8 and/or IL-6 production compared
to non-CF cells [4,6-11]. In addition, in some, but not all,
model systems binding of P. aeruginosa to CF airway epi-
thelial cells is in excess of its binding to non-CF cells [12-
16]. Taken together, these data have been interpreted to
mean that the excess cytokine responses in CF epithelium
are due to increased stimulus applied at the cell surface by
elevated bacterial adherence in the CF phenotype cells
[15].
Our prior studies, in two separate cell model systems,
have shown that there is increase in available asialoGM1
(aGM1), which binds to P. aeruginosa pilin and flagellin
and serves as a major ligand for this organism, on the CF
member of the cell pair [17-19]. In these same cell pairs,
there is an increased response of IL-8, IL-6, and granulo-
cyte macrophage colony stimulating factor (GM-CSF) to a
laboratory strain of P. aeruginosa, PAO1, in the CF mem-
ber of the pair [6]. However, these studies did not directly
address the relationship between PAO1 binding and the
cytokine response. In order to test the hypothesis that the
cytokine response of CF phenotype airway epithelial cells
to PAO1 can be attributed solely to increased pseu-
domonas adherence, we took several approaches. First, we
determined whether cytokine responses and P. aeruginosa
adherence changed in parallel with increasing amounts of
added PAO1. Second, we manipulated the cells to alter
surface receptor access to P. aeruginosa. We incubated CF
and non-CF cells with exogenous aGM1 to increase the
binding sites for P. aeruginosa, and treated them with neu-
raminidase to add or expose more desialylated binding
sites. We then compared cytokine production and binding
of PAO1 in the altered cell preparations. In the cell lines
that form tight junctions, we increased access to native P.
aeruginosa binding sites on the basolateral surface by dis-
rupting tight junctions [20], then tested the ability of the
treated cells to respond to PAO1. Our results indicate that
excess cytokine responses in CF airway epithelial cells do
not correlate well with adherence of P. aeruginosa, and
suggest that the excess cytokine response cannot result
solely from the increased adherence of P. aeruginosa.
Methods
Cell lines
pCEP and pCEP-R cell lines
The development and maintenance of this matched pair
of human tracheal epithelial cells derived from SV40
transformed human tracheal epithelial cells (9HTEo-,
kindly provided by Dieter Gruenert, University of Calif,
San Francisco) have been described previously and these
methods were followed here [6,18,21].
16HBE-14o- AS and S cell lines
The development and maintenance of these cell lines have
been described previously and these were the methods
used [6,22].
Bacteria
The laboratory isolate PAO1 and its GFP derivative strain
were kindly provided by Alice Prince, Columbia Univer-
sity, NY, and were grown as previously described [6].
PAO1 Binding Assay
Green fluorescent protein (GFP)-PAO1 at 109 CFU were
incubated with cell monolayers of pCEP or pCEP-R cells
for 1 hr. Cells were washed with Hanks buffered salt solu-
tion (HBSS), lysed, and GFP fluorescence quantitated by
fluorimeter. Serial dilutions of GFP-PAO1 were used to
assess the change in GFP-PAO1 binding over a range of
concentrations.
Stimulation of cytokine production by P. aeruginosa
These studies were performed as previously described [6].
Briefly, 9/HTEo- cells, pCEP and pCEP-R, were plated at a
density of 1 × 106 cells per well on vitrogen-coated 24-well
plates, and the sense and antisense clones of 16HBEo-
cells were plated at density of 1 × 106 cells per 12 mm Mil-
licell HA filter. Eighteen to 24 hr before the experiment,
cells were switched to serum-free media, because PAO1 is
serum-sensitive. Washed bacterial aliquots (0.5 ml/well)
were incubated for 60 min with the confluent monolayers
of epithelial cells at 37°C. Non-treated control wells were
processed similarly with HBSS alone. For polarized
16HBE-14o- cells on filters, PAO1 and other treatments
were applied to the apical surface only. As a positive con-
trol, cells were stimulated for 1 hr with IL-1β  (100 ng/ml)
and tumor necrosis factor (TNF)-α  (100 ng/ml), (Sigma,
St. Louis, MO). Cell monolayers were washed 3 times in
Hanks Buffered Salt Solution (HBSS), then incubated for
24 hr in 0.5 ml serum-free cell culture medium containing
100  µg/ml gentamicin. Media were collected and ana-
lyzed for IL-8 and IL-6 by enzyme linked immunoadsorb-
ant assay (ELISA), and normalized to the protein
concentration of the lysed cells.
Glycophospholipid addition and fluorescence microscopy
250 µg (or 5 µl of 10 mg/ml stock in dimethylsulfoxide
(DMSO)) monosialoganglioside (GM1) or gangliotetrao-
syl ceramide (aGM1) (Matreya, Inc), was added in 0.195
ml of serum-free media for 1 hr with gentle rocking to
pCEP and pCEP-RF cells. Cells were then washed twice
with HBSS, and PAO1 was applied as above. Immunoflu-
orescence was performed by incubating the cells with a
1:1000 dilution of rabbit polyclonal anti-aGM1 (WakoRespiratory Research 2005, 6:69 http://respiratory-research.com/content/6/1/69
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Pure Chemical Industries Ltd, Osaka, Japan) in phosphate
buffered saline (PBS) with 0.1% bovine serum albumin
(BSA), for 1 hr at 37°C, followed by two washes with PBS,
and fixation with 4% paraformaldehyde (PFA) for 1 hr,
and washed with PBS. Monolayers were then incubated
with FITC- conjugated goat anti-rabbit antibody (Jackson
Immunoresearch Laboratories Inc.) diluted 1:100 PBS
with 0.1% BSA for 1 hr at room temperature, washed with
PBS and fixed again with 4% PFA for 20 minutes. Cells
were mounted under coverslip with Fluoromount G anti-
fade (Southern Biotechnology Associates, Inc, Birming-
ham, AL) and visualized by fluorescence microsopy using
a fluorescein filter set.
FITC-Peanut Agglutinin (PNA, which binds to aGM1), or
FITC-Maakia Amurensis lectin (MAL I, which recognizes
sialic acid in α 2,3 linkages to GlcNAC), at 100 µg in 300
ml PBS, was incubated with cells for 30 minutes after fix-
ation in 4% PFA, washed with PBS and fixed in methanol
for 10 minutes. Cells were mounted under coverslip and
visualized by epifluorescent microscopy with a Zeiss 100
Axiovert, 40X water immersion objective, NA 0.75, and
FITC filter set. Fluorescent-conjugated lectins were pur-
chased from Vector Laboratories, Burlingame, CA.
Neuraminidase treatment
Neuraminidase from Clostridium perfringens, which
removes sialic acid in α 2,3, α 2,6 or α 2,8- linkages (5 U)
or Salmonella typhimurium neuraminidase, which prefer-
entially removes α 2,3- linked sialic acid residues, (22.5 U)
(Sigma, St. Louis, MO), was added to 200 µl serum-free
media per well for 1 hr prior to PAO1 exposure. Effective-
ness of treament was assessed qualitatively by immun-
ofluorescent microscopy of fixed cells as described above.
Treatments to disrupt tight junctions
The integrity of junctional complexes was diminished in
two ways: first, by calcium chelation by incubating
16HBEo- monolayers with 30 mM EGTA in PBS buffer, for
60 min, or second, by overnight incubation with 250 µg
of a monoclonal mouse E-cadherin antibody (Zymed Lab-
oratories, San Francisco, CA) in 0.5 ml serum-free media.
Transepithelial Resistance
Transepithelial resistance (TER) of cell monolayers grown
on transwell filters was measured with a Millicell-ERS
resistance system (Millipore, Bedford, MA) meter and
STX-2 Electrodes (World Precision Instruments, Inc). Elec-
trodes were equilibrated in cell culture media at room
temperature, and measurements made with one electrode
placed inside the insert and the other outside in the baso-
lateral media. Baseline resistance of filters alone was
determined. The TER of the polarized monolayers on fil-
ters was determined prior to treatments, immediately fol-
lowing treatment, and then at the final 24 hr time point.
Cytotoxicity Assays
To quantify cytotoxity of treatments, the concentration of
lactate dehydrogenase (LDH) released from cells into the
medium was measured using materials purchased from
Sigma Chemical Co. (St. Louis, MO) at the same time
point as was used for measuring cytokines.
Statistics
Results are expressed as mean ± standard error of the
mean (SEM). All experiments reported were repeated on
at least three separate occasions, and each individual
cytokine experiment was performed in triplicate wells,
except as specified in the legends of Figures 4 and 6. To
combine multiple experiments of the 9/HTEo- cell lines,
the secreted cytokine concentration (pg/mg protein) of
109 CFU of PAO1-stimulated pCEP-R cells at 24 hr. was
set to 100% for each experiment, and other concentra-
tions are expressed relative to this value. Most analysis was
performed by t-test, some by ANOVA, using Sigma Plot
software (SPSS, Inc., Chicago, IL). Results were considered
significant when p ≤  0.05.
Results
Binding of GFP-PAO1 to the cell lines
Our prior data indicate that for both the 16HBEo- AS and
S cell pairs, and for the 9HTEo- pCEP and pCEP-R cell
pairs, IL-8 and IL-6 production increased with addition of
increasing amounts of PAO1 over the range of 107 to 109
organisms [6]. Figure 1 illustrates the changes in GFP-
PAO1 binding with increasing concentrations of bacteria.
For the 16 HBEo- cells, PAO1-GFP binding also increased
with added PAO1 from 107  to 109  CFU/mL, but for
9HTEo- cells, binding increased from 106 to 108 CFU/mL
but did not increase not further with 109 CFU/mL, even
though the cytokine responses did. Binding of GFP-PAO1
was similar in untreated 16HBEo- sense (S) and antisense
(AS) cell lines, at all concentrations, and in untreated
9HTEo-pCEP and pCEP-R cell lines, at all concentrations
(Figure 1). Therefore, the previously reported increase in
available aGM1 in the CF member of the pairs, confirmed
below, was not necessarily associated with increased GFP-
PAO1 binding, and increased cytokine production was
not invariably associated with increased binding of GFP-
PAO1.
Providing additional P. aeruginosa binding sites by 
addition of asialoGM1
Others report that exogenous aGM1 is incorporated into
the cell membrane and provides additional binding sites
for  P. aeruginosa [23]. We therefore incubated our cell
lines with exogenous a GM1 and measured cell-associated
aGM1, GFP-PAO1 binding, and cytokine responses. Incu-
bation of the 9/HTEo- cell lines with aGM1 resulted in
increased cell-associated aGM1, as demonstrated both by
specific antibody binding, and by binding of PNA, a lectinRespiratory Research 2005, 6:69 http://respiratory-research.com/content/6/1/69
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which recognizes aGM1 (Figure 2). There was no change
in LDH release (Table 1). Prior to treatment, as reported
previously [19], the 9HTEo-pCEP-R cells displayed more
aGM1 than the 9HTEo-pCEP cells (Figure 2A vs E for
aGM1 and C vs G for PNA), but following treatment, the
two cell lines had similar aGM1 antibody fluorescence
and PNA fluorescence (Figure 2, B vs F and D vs H). Prior
to treatment, binding of GFP-PAO1 to the two cell types is
equivalent, (Figure 1, Table 1). After aGM1 incubation,
both cell lines showed increased GFP-PAO1 binding, but
more so in the non-CF than the CF phenotype cells (Table
1). Untreated CF phenotype cells had increased IL-8 and
IL-6 production in response to PAO1 compared to nor-
mal, as previously reported [6]. Following incubation,
although aGM1 and PAO1 binding increased in the nor-
mal cells, cytokine production did not, but IL-8 produc-
tion by the CF phenotype cells showed a statistically
significant increase (Figure 3). As a control, the cells were
loaded with GM1, which is less efficient in binding PAO1.
Following GM1 preincubation, despite the increase in
Binding of GFP-PAO1 to airway epithelial cells Figure 1
Binding of GFP-PAO1 to airway epithelial cells. GFP-PAO1 was added to cultured cells for one hour at 37°C, washed, and 
the cultures lysed and fluorescence determined (and expressed in arbitrary units). A and B, 9HTEo- cells, C, 16 HBEo- cells. 
For the 9HTEo- cells, binding appears to saturate at about 108 organisms/well (A) but for 16 HBEo- cells, binding increases with 
increasing dose of bacteria over the range tested (C). The 9HTEo- cells change GFP-PAO1 binding with addition of a GM1 or 
GM1, or with neuraminidase treatment (B) (*, significantly different from no treatment, p < 0.05), but the 16 HBEo- cells do 
not (C).
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PAO1-GFP binding (Table 1), there was a significant
decrease in production of both IL-8 and IL-6 by the CF
phenotype cell line (Figure 3), possibly because more
PAO1 was bound at sites that do not initiate an inflamma-
tory signal. No changes in cytokine response to TNF-α /IL-
1β  occurred following incubation with aGM1 or GM1
(data not shown).
In polarized epithelial cell lines (16BHBEo-), the addition
of aGM1 or GM1 did not increase GFP-PAO1 binding
(Table 2, Figure 1), nor alter the proinflammatory
cytokine response to P. aeruginosa or TNF-α /IL-1β  (data
not shown).
Providing additional P. aeruginosa binding sites by 
enzymatic removal of sialic acid
C. perfringens neuraminidase removes sialic acid in the
α 2,3, α 2,6, and α 2,8 linkages. S. typhimurium neuramini-
dase attacks the α 2,3 linkage preferentially. Increases in
binding of PNA, which recognizes aGM1, are evident for
both cell lines following neuraminidase treatment (Figure
4A, panels B,C,E,F). This increase may result from relief of
steric hindrance to binding to existing sites, since some
investigators find that the final sialic acid residue is not
removed by their action. Nevertheless, MAL I, a lectin
which recognizes sialic acid in terminal α 2,3 linkages,
shows visible decrease in surface binding in the non-CF
Exogenous aGM1 is incorporated into 9HTEo-pCEP and pCEP-R Figure 2
Exogenous aGM1 is incorporated into 9HTEo-pCEP and pCEP-R. pCEP (a-d) and pCEP-R (e-h) cells were incubated with 
either vehicle (a,c,e,g) or aGM1 (b,d,f,h) and fluorescent staining with either antibody to aGM1 and FITC secondary (b,f) or 
FITC- conjugated PNA (D,H) was performed. In the untreated state, there is more binding of antibody to aGM1 or PNA to 
pCEP-R than pCEP cells. After incubation with aGM1, fluorescence patterns are similar for pCEP and pCEP-R cells with anti-
body to aGM1 (b,f) and PNA (d,h). Micrographs are representative of 3 separate experiments.
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phenotype cells that have been treated with C. perfringens
neuraminidase (Figure 4B, panels B and E), but the
change in MAL I fluorescence after S. typhimurium neu-
raminidase is less clear (Figure 4B, panels E and F).
Clostridium perfringens neuraminidase treatment signifi-
cantly increased GFP-PAO1 binding on the non-CF cell
line (Table 1), but the cytokine responses to PAO1 or
TNF-α /IL-1β  did not increase in the non-CF cells (Figure
4). There was no significant increase in GFP-PAO1 bind-
ing in the CF phenotype cells, even though they showed
increased IL-8 and IL-6 responses following treatment
with the broad spectrum neuraminidase of C. perfringens.
Following treatment with the more specific S. typhimurium
enzyme only IL-8 was increased (Figure 5).
C. perfringens neuraminidase treatment did not alter either
the IL-8 response or PAO1 binding in the polarized cell
lines. However, the IL-6 response of the CF phenotype
line was reduced (data not shown).
Exposure of basolateral receptors to P. aeruginosa
We expected that disrupting the tight junctions in the
monolayer would permit PAO1, applied to the apical sur-
face, to access basolateral receptors that were not available
when the monolayer was intact [23], and thereby would
increase the cytokine response to PAO1. The tight junc-
tions in both the Sense (control) and Antisense-treated
(CF phenotype) 16 HBEo- cell lines were disrupted by
treatment with EGTA or antibodies to E-cadherin, as
shown by the decrease in transepithelial resistance follow-
ing these treatments (Table 2). Incubation of the filters
without disrupting agents for the time course of the
experiment did not alter transepithelial resistance. When
incubation with the disrupting agents was combined with
P. aeruginosa exposure, the transepithelial resistance fell
even further, to approximate that of the filters alone. The
Table 1: Binding of PAO1 and LDH release by 9HTEo- cell lines
pCEP pCEP-R
LDH (U/ml) GFP -PA01 (RFU) LDH (U/ml) GFP-PA01 (RFU)
PA 8.83 ± 2.5 0.3483 ± 0.12 4.64 ± 0.7* 0.3745 ± 0.123
PA + EGTA 3.77 ± 0.9 ND 2.82 ± 0.0 ND
PA + aGM1 2.36 ± 0.5 0.7764 ± 0.037† 3.3 ± 0.5 0.5489 ± 0.085*†
PA + GM1 2.83 ± 0.0 0.6929 ± 0.049† 1.89 ± 0.0 0.4598 ± 0.090*
PA + C.p. ND 0.6350 ± 0.091† ND 0.4359 ± 0.079*
No treatment 4.79 ± 1.0 ND 2.44 ± 0.9 * ND
EGTA alone 2.36 ± 0.5 ND 4.24 ± 0.5 ND
aGM1 alone 3.3 ± 0.5 ND 2.83 ± 0.9 ND
GM1 alone 2.83 ± 0.9 ND 3.3 ± 0.5 ND
*Different from pCEP congener, p < 0.05
† Different from no treatment, p < 0.05
IL-8 and IL-6 responses to PAO1 or no stimulation, with or  without preincubation with aGM1 or GM1 Figure 3
IL-8 and IL-6 responses to PAO1 or no stimulation, with 
or without preincubation with aGM1 or GM1. *, different 
from no treatment, p < 0.05.
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non CF phenotype cell lines (pCEP and 16HBEo- Sense)
show both a greater transepithelial resistance and a greater
amount of lactate dehydrogenase in the medium at base-
line than CF phenotype cell lines (pCEP-R and 16HBEo-
AntiSense) (Tables 1 and 2). Apoptosis is reported to be
reduced in CF versus non-CF cell lines [24,25], which may
account for the lesser release of LDH. However, none of
the treatments that alter PA receptor availability further
disrupted the integrity of cellular membranes or increased
LDH release (Table 1).
Although the disruptive treatments had similar effects on
resistance in CF and nonCF phenotype cells, the cytokine
response to PAO1 increased with disruption of tight junc-
tions only in the CF phenotype cells. There was no
increase in cytokine production following TNF-α /IL-1β
stimulation: in fact in one sample a small decrease was
seen (Figure 6). In order to test whether the EGTA treat-
ment, in and of itself, altered cytokine production by air-
way epithelial cell lines, we treated non-polarized 9HTEo-
cell lines with EGTA in the same manner as it was applied
to the 16HBEo- cells. There was a slight but statistically
significant decrease in IL-6 in response to PAO1 produc-
Lectin binding to 9HTEo- cell pairs following treatment with neuraminidase Figure 4
Lectin binding to 9HTEo- cell pairs following treatment with neuraminidase. A. FITC-PNA binding to pCEP (a-c) and 
pCEP-RF (d-f) cells before (a,d) and after treatment with Clostridium perfringens neuraminidase (b,e) or Salmonella typhimurium 
neuraminidase (c,f). Binding is similar to pCEP and pCEP-R cells after treatment. Micrographs are representative of two sepa-
rate experiments. B. FITC-MALI binding to pCEP (a-c) and pCEP-RF (d-f) cells before (a,d) and after treatment with C. perfrin-
gens (b,e), or S. typhimurium neuraminidase (c,f).
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tion by the CF phenotype cells, but no other changes (data
not shown). Since in the polarized cells, EGTA pretreat-
ment resulted in increased cytokine production in the CF
cell line, and if anything, EGTA treatment of nonpolarized
cells produced no such increase, we ascribe the increases
in the polarized cells to disruption of the tight junctions
and not to some nonspecific effect of EGTA.
Discussion
In some model systems, CF airway epithelial cells produce
more IL-8 and/or IL-6 than non CF cells in response to P.
aeruginosa, and in some model systems, CF cell surfaces
bind the organism to a greater extent than normal [6-16].
The studies reported here were designed to test the
hypothesis that increased binding sites for PAO1 result in
increased stimulus and increased cytokine production in
Table 2: Transepithelial resistance, LDH release and PAO1 binding to 16HBEo- cell lines.
Sense AntiSense
Resistance 
(Ω *cm2)
LDH (u) GFP-PA01 (RFU) Resistance 
(Ω *cm2)
LDH (u) GFP-PA01 (RFU)
PA alone 229.0 ± 13.8 4.08 ± 0.4 0.6056 ± 0.078 217.85 ± 8.0 2.12 ± 0.2* 0.5753 ± 0.021
PA + EGTA 136.14 ± 6.1 2.42 ± 0.3 ND 142.43 ± 5.9 2.78 ± 0.6 ND
PA + ECAD 126.0 ± 2.3 2.95 ± 0.3 ND 131.0 ± 1.3 2.99 ± 0.4 ND
PA + aGM1 ND ND 0.6456 ± 0.051 ND ND 0.7437 ± 0.165†
PA + C.p. ND ND 0.5851 ± 0.031 ND ND 0.5154 ± 0.031
No treatment 316.54 ± 10.5 4.31 ± 0.7 ND 225.72 ± 2.9 1.24 ± 0.1* ND
EGTA alone 213.58 ± 15.2 3.22 ± 0.0 ND 202.4 ± 4.3 0.86 ± 0.0 ND
ECAD alone 147.186 ± 14.4 3.73 ± 0.0 ND 151.09 ± 6.2 1.07 ± 0.2 ND
* Different from Sense congener, p < 0.05
†Different from no aGM1, p < 0.05
Neuraminidase treatment alters cytokine responses in 9HTEo- cell lines Figure 5
Neuraminidase treatment alters cytokine responses in 9HTEo- cell lines. IL-8 (A) and IL-6 (B) responses to 109 CFU 
PAO1 or TNF-α /IL-1β  are shown. For 9HTEo-pCEP cells, only IL-8 secretion increased, and only following treatment with C. 
perfringens neuraminidase (C.p.), not with the enzyme from S. typhimurium. However, 9HTEo-pCEP-R cells showed increased 
IL-8 response to PAO1 following treatment with either enzyme and IL-6 response to C.p. neuraminidase. Three separate 
experiments were performed, each with triplicate wells. (*, different from untreated samples, p < 0.05).
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response to PAO1 in airway epithelial cells (Figure 7). The
hypothesis was not supported. Surprisingly, although
aGM1 was increased on the CF phenotype cells studied
here under basal conditions, GFP-PAO1 binding was not,
so the increased cytokine responses of CF phenotype cells
to PAO1 in the basal state [6] cannot be attributed solely
to increased PAO1 adherence. Moreover, increasing the
binding of PAO1 to non-polarized normal airway
epithelial cell lines (9HTEo-pCEP), either by adding
aGM1 or by cleaving sialic acid at the cell surface, does not
change the cytokine responses to PAO1. CF phenotype
cells (9HTEo-pCEP-R) still respond to PAO1 with greater
cytokine release than their matched normal counterparts,
despite significantly less PAO1 adherence than normal
Treatments that disrupt tight junctions increase the PAO1-stimulated IL-8 response, but not the TNF-α /IL-1β  stimulated  response of CF-phenotype cells Figure 6
Treatments that disrupt tight junctions increase the PAO1-stimulated IL-8 response, but not the TNF-α /IL-1β  stimu-
lated response of CF-phenotype cells. 16HBEo- Sense (open bars) and Antisense (black bars) monolayers on filters were 
pretreated for 60 minutes with 30 mM EGTA prior to 1 hr. stimulation with 109 CFU PAO1/(EGTA, n = 5 independent exper-
iments, each with triplicate wells), or an overnight incubation with 250 µg monoclonal antibody to E-Cadherin (ECAD, n = 3 
independent experiments, each with triplicate wells), and the IL-8 (A, C) and IL-6 (B, D) response measured 24 H later by 
ELISA. The IL-8 response to PAO1 was significantly (*) increased in the 16HBE-Antisense cells following pretreatment with E-
Cadherin antibody (p = 0.034) or EGTA (p < 0.001). The 16HBEo-AS cells produced significantly more IL-8 than their sense 
congeners (p < 0.05). There was a significant (*) reduction in the IL-6 (p = 0.05) and IL-8 (p = 0.041) response to TNF-α /IL-1β  
after overnight incubation to the E-cadherin antibody (n = one experiment of triplicate wells). There is a significant increase of 
IL-8 in response to PAO1 prior to treatment in the CF phenotype cells compared to normal (p = 0.001).
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phenotype cells. For matched polarized cell lines
(16HBEo-), there was little change in PAO1 binding from
adding aGM1 or cleaving sialic acid at the cell surface in
either the CF or the non CF line, and little change in the
cytokine response to PAO1. However, when the basola-
teral surface was made available for PAO1 binding by dis-
ruption of the tight junctions, cytokine responses to PAO1
increased only in the CF phenotype cells.
It is likely that there are multiple ligands for PAO1 on air-
way epithelial cells. Two that have been identified are
aGM1 and CFTR itself [18,24], and it is likely that GM1 is
a weak binding site as well. Thus, it is possible that GFP-
PAO1 adheres more to increased aGM1 binding sites on
the CF cells (which apparently signal for inflammatory
mediators) but may adhere less at other sites, perhaps at
CFTR itself, making it appear that adherence has little rela-
tion to cytokine response when in fact a only a subset of
pseudomonas receptors is responsible for the increased
response. Nevertheless, attempts to increase aGM1
directly did not produce the expected changes in the
cytokine responses of non-CF cell lines, but did enhance
the responses of the CF cell lines. Adding exogenous
aGM1 effectively equalized surface aGM1 in both normal
Cartoon comparing CF and non-CF epithelial cell responses to P. aeruginosa and illustrating two hypotheses to explain the  increased cytokine response from CF airway epithelial cells Figure 7
Cartoon comparing CF and non-CF epithelial cell responses to P. aeruginosa and illustrating two hypotheses to 
explain the increased cytokine response from CF airway epithelial cells. Bacterial adherence to the cell stimulates an 
intracellular signaling cascade. CF cells produce more IL-8 and IL-6 than non-CF cells. In the first hypothesis, increased bacterial 
adherence to the CF cell leads to increased signal, with consequent increase in IL-8 and IL-6 secretion. In the second hypothe-
sis, the CF cell responds to each binding event with amplification of the signal compared to non-CF cells, and increased IL-8 and 
IL-6 secretion.
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and CF cell lines as measured by antibodies to aGM1 or
PNA lectin binding, and actually increased GFP-PAO1
binding to the non CF relative to the CF cell line. Were P.
aeruginosa binding to aGM1 the principal determinant of
the pro-inflammatory cytokine response, one would
expect that the response of the normal cell lines under
these conditions would equal or exceed that of the CF
phenotype cell lines. However, the CF cell lines still pro-
duced more IL-8 in response to PAO1. Although one
could argue that increasing aGM1 in this manner might
produce binding sites that are not connected to the sign-
aling machinery, others have shown that exogenous
aGM1 incorporates into cellular membranes, increases
the binding of P. aeruginosa, and augments biological
responses to P. aeruginosa, including cytotoxicity, internal-
ization and the apoptotic response [23]. Moreover, the CF
cell line treated in this manner did augment its cytokine
response to PAO1 (but not to another stimulus, TNF-α /IL-
1β , eliminating the possibility of a generalized increase in
cytokine production). In contrast, GM1 preincubation,
which also resulted in increased PAO1 binding, did not
increase the IL-8 response to PAO1: in this case, the
increase in binding of P. aeruginosa in the GM1-incubated
cells is probably not coupled to a proinflammatory
signaling cascade. Association of PAO1 with a non-signal-
ing GM1 ligand could block access to aGM1 receptors,
actually reducing the response.
Another attempt to alter access to aGM1 binding sites also
did not reveal association between binding and
inflammatory response. Treating the cells with the broad
spectrum neuraminidase from C. perfringens resulted in
significantly increased lectin binding sites and IL-8
response to PAO1 (but not to TNF-α /IL-1β ) in both CF
phenotype and non-CF phenotype 9HTEo- cells. How-
ever, the excess cytokine response of the CF cells was pre-
served following neuraminidase treatment, despite
equalizing apparent binding of PAO1. Neuraminidase
from S. typhimurium, which preferentially removes sialic
acid in the α 2,3 linkage, produced a significant increase in
IL-8 production in response to PAO1 only in the CF phe-
notype cells.
We made no attempt to assess with lectin binding or spe-
cific antibody the nature of the basolateral binding sites
revealed in polarized cultures by disruption of tight
junctions. Others have shown that allowing access to
basolateral receptors greatly increases P. aeruginosa bind-
ing, cytotoxicity, internalization, and apoptosis
independent of CFTR [23,26,27]. Nevertheless, opening
tight junctions did not enhance PAO1-stimulated
cytokine production in the non-CF cell line, whereas it did
in the CF congener.
Conclusion
The data presented here indicate that the increased
cytokine responses in CF airway epithelial cells to P. aeru-
ginosa cannot be attributed solely to increased adherence
of the organism. There are several implications of this
finding. First, these data focus attention on alternative
hypotheses to explain the increased inflammatory
response of the CF airway epithelial cell (Figure 7). Our
data make the hypothesis that increased pseudomonas
binding entirely accounts for the increased inflammatory
response of CF epithelium [15] much less likely. Alterna-
tively, there may be increased amplification of the signal
from the bacterium in CF cells to account for the increased
response. Considerable attention has been paid to the
excess activation of NF-κ B in CF epithelial cells. Some
investigators find that there is activation of this transcrip-
tion factor even in the unstimulated state in CF epithelial
cells, and others find that it is activated to excess only
under conditions of stimulation. This pivotal transcrip-
tion factor could account for a panoply of abnormalities,
including the excess cytokine production documented
here, but also increased release of MMP-9 and reduced
apoptosis of CF airway epithelial cells. Others have pro-
posed that in CF there is failure of anti-inflammatory con-
trol mechanisms such as IL-10, NO, or transcription
factors that compete with NF-κ B for helicases, or there
may be subtle abnormalities in both the pro- and anti-
inflammatory arms of the cascade [reviewed in [4]]. A sec-
ond caveat raised by our data is that disrupting tight junc-
tions in the CF epithelium can markedly increase
inflammatory responses to P. aeruginosa, even if the bacte-
ria are applied only briefly and the cells are given oppor-
tunity to recover. Moreover, the combination of
disrupting agents and P. aeruginosa produced complete
loss of the electrophysiologic barrier in a manner that
EDTA or anti-E-cadherin did not. These observations sig-
nal caution for therapeutic strategies that propose to
access the basolateral surface of CF airway epithelial cells
by disrupting the tight junctions in vivo [28,29], espe-
cially in patients already infected with P. aeruginosa.
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